Finland· FI-REL-REL7425
Barolyn
A metolazone product, registered in Finland by Schering Oy. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Metolazone is registered in 10 of 19 countries.
Countries holding a registration under ATC C03BA08 (metolazone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Metolazone · ATC C03BA08
10 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of metolazone costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.19 in Italy to $1.25 in Switzerland — a ×6.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Metolazone · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.25
- IT Italy$0.19
The record
At a glance
Fimea (Finland)- Manufacturer
- Schering Oy
- Country
- Finland (FI)
- ATC code
- C03BA08
- ATC class
- Metolazone
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
326 interactions on record for metolazone.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metolazone · interactions on record
326 records
- 4 severe
- 208 moderate
- 19 minor
- 91 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Aminolevulinic acidL01XD04severe
- Arsenic trioxideL01XX27severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C03BA08
Metolazone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/942c3276-07f7-4c93-9fb2-bed21f39e7c6 GET /v1/drugs/942c3276-07f7-4c93-9fb2-bed21f39e7c6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "5",
"form": "tabletti",
"route": null,
"ddd_unit": "mg",
"strength": "2.5 mg",
"atc_label": "metolatsoni",
"ma_number": "7623",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL7425",
"authorised_at": "1978-10-11"
}See everything about metolazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.